The Role of 6-Iodo-4(H)-quinazolinone in Modern Pharmaceutical Synthesis
The landscape of pharmaceutical development is constantly evolving, with a continuous demand for sophisticated chemical intermediates that enable the creation of targeted and effective therapies. Among these critical compounds, 6-Iodo-4(H)-quinazolinone stands out as a pivotal building block, particularly in the realm of oncology drug synthesis. As a trusted supplier in China, NINGBO INNO PHARMCHEM CO.,LTD. is at the forefront of providing this high-purity intermediate to researchers and manufacturers worldwide.
6-Iodo-4(H)-quinazolinone, identified by its CAS number 16064-08-7, is a quinazolinone derivative characterized by its specific chemical structure and properties. Its physical form is typically a brown powder, with a notable melting point range of 272-274°C. The molecule's utility is amplified by its role as a precursor in the multi-step synthesis of Lapatinib, a targeted therapy used to treat certain types of breast cancer and other solid tumors. The ability to buy this intermediate ensures that pharmaceutical companies can reliably access the necessary components for developing and producing life-saving medications.
The synthesis of 6-Iodo-4(H)-quinazolinone involves meticulous chemical processes designed to achieve high purity, which is paramount for its application in pharmaceutical research and development. As a primary Lapatinib intermediate, its consistent quality directly impacts the efficacy and safety of the final drug product. Pharmaceutical companies looking to optimize their R&D pipeline often seek out dependable sources for such essential intermediates. The price and availability of these chemicals can significantly influence the speed and cost-effectiveness of drug development programs.
Beyond Lapatinib, quinazolinone derivatives, in general, are a class of compounds that have garnered significant attention in medicinal chemistry due to their diverse pharmacological activities. Researchers are continually exploring new applications and modifications of these structures. The availability of intermediates like 6-Iodo-4(H)-quinazolinone facilitates this exploration, allowing for the synthesis of novel drug candidates and the investigation of new therapeutic pathways. Understanding the chemical synthesis routes and the quality control standards applied to these intermediates is crucial for any organization involved in pharmaceutical manufacturing. NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing the highest standards, ensuring that each batch meets the stringent requirements of the pharmaceutical industry. The ongoing demand for effective cancer treatments means that the role of reliable suppliers of intermediates like 6-Iodo-4(H)-quinazolinone will only continue to grow.
6-Iodo-4(H)-quinazolinone, identified by its CAS number 16064-08-7, is a quinazolinone derivative characterized by its specific chemical structure and properties. Its physical form is typically a brown powder, with a notable melting point range of 272-274°C. The molecule's utility is amplified by its role as a precursor in the multi-step synthesis of Lapatinib, a targeted therapy used to treat certain types of breast cancer and other solid tumors. The ability to buy this intermediate ensures that pharmaceutical companies can reliably access the necessary components for developing and producing life-saving medications.
The synthesis of 6-Iodo-4(H)-quinazolinone involves meticulous chemical processes designed to achieve high purity, which is paramount for its application in pharmaceutical research and development. As a primary Lapatinib intermediate, its consistent quality directly impacts the efficacy and safety of the final drug product. Pharmaceutical companies looking to optimize their R&D pipeline often seek out dependable sources for such essential intermediates. The price and availability of these chemicals can significantly influence the speed and cost-effectiveness of drug development programs.
Beyond Lapatinib, quinazolinone derivatives, in general, are a class of compounds that have garnered significant attention in medicinal chemistry due to their diverse pharmacological activities. Researchers are continually exploring new applications and modifications of these structures. The availability of intermediates like 6-Iodo-4(H)-quinazolinone facilitates this exploration, allowing for the synthesis of novel drug candidates and the investigation of new therapeutic pathways. Understanding the chemical synthesis routes and the quality control standards applied to these intermediates is crucial for any organization involved in pharmaceutical manufacturing. NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing the highest standards, ensuring that each batch meets the stringent requirements of the pharmaceutical industry. The ongoing demand for effective cancer treatments means that the role of reliable suppliers of intermediates like 6-Iodo-4(H)-quinazolinone will only continue to grow.
Perspectives & Insights
Future Origin 2025
“Its physical form is typically a brown powder, with a notable melting point range of 272-274°C.”
Core Analyst 01
“The molecule's utility is amplified by its role as a precursor in the multi-step synthesis of Lapatinib, a targeted therapy used to treat certain types of breast cancer and other solid tumors.”
Silicon Seeker One
“The ability to buy this intermediate ensures that pharmaceutical companies can reliably access the necessary components for developing and producing life-saving medications.”